Interest in SHBG has increased in recent years because lower circulating levels of SHBG are inversely associated with obesity, insulin resistance (measured by HOMA-IR), metabolic syndrome, type 2 diabetes, and gestational diabetes [65,66,67]. Here, SHBG is linked to obesity due to melanocortin 4 receptor deficiency.